• Vasoactive Intestinal Polypeptide (VIP)
  • Prolactin
  • 5-AMP-Activated Protein Kinase, Gamma-2 Subunit (PRKAG2) Mutation Analysis
  • Bruton Tyrosine Kinase (BTK) Protein Expression by Flow Cytometry
  • Allergy Screen
  • Cytochrome P450 2C19 (CYP2C19) Genotyping
  • Chitotriosidase, Serum
  • Acanthamoeba and Naegleria Culture and Stains, Corneal Scraping
  • Oncotype DX, Breast Ductal Carcinoma in Situ (DCIS)
  • Cancer Antigen (CA) 72-4
  • LDS
  • Sign up
  • Log in
  • LDS
  • /Medical Tests
  • /Bladder Tumor Antigen (BTA)
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • LOINC
  • ICD10
  • Additional ICD10
  • References
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • LOINC
  • ICD10
  • Additional ICD10
  • References

Bladder Tumor Antigen (BTA)
Medical Test

Clinical Utility
Access to Bladder Tumor Antigen (BTA) is restricted.
Loading...